NCT03693950View on ClinicalTrials.gov

The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

July 3, 2017

Study Completion Date

July 3, 2017

Conditions
Healthy
Interventions
BIOLOGICAL

BCD-066

BCD-066 will be administered once a week intravenously in a dose 1 µg/kg

BIOLOGICAL

Aranesp

Aranesp will be administered once a week intravenously in a dose 1 µg/kg

Trial Locations (1)

198515

BIOCAD, Saint Petersburg

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY